A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers (Q45302240)
Jump to navigation
Jump to search
scientific article published in December 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers |
scientific article published in December 2000 |
Statements
1 reference
A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers (English)
1 reference
Greenberg HE
1 reference
Gottesdiener K
1 reference
Huntington M
1 reference
Wong P
1 reference
Larson P
1 reference
Wildonger L
1 reference
Gillen L
1 reference
Dorval E
1 reference
Waldman SA
1 reference
1 December 2000
1 reference
1 reference
40
1 reference
12 Pt 2
1 reference
1509-1515
1 reference
Identifiers
1 reference